SCHEMBL5599635

SCHEMBL5599635

COc1ccc2c(c1)N(C(=O)OC(C)(C)C)CC21CCNCC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.38
HDAC8 Q9BY41 2/20 0.38
HDAC6 Q9UBN7 2/20 0.38
PDE4B Q07343 1/20 0.38
KDM1A O60341 1/20 0.36
HTR3E A5X5Y0 1/20 0.36
HTR3B O95264 1/20 0.36
HTR3A P46098 1/20 0.36
HTR3D Q70Z44 1/20 0.36
HTR3C Q8WXA8 1/20 0.36
P2RY1 P47900 1/20 0.36
ALDH1A1 P00352 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C19 P33261 1/20 0.35
STS P08842 1/20 0.35
HTT P42858 1/20 0.35
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
NOTUM Q6P988 1/20 0.34
CTSD P07339 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5599315 0.85 DPP4 (0.37) HDAC1HDAC8HDAC6PDE4BKDM1A
SCHEMBL30413026 0.82 NOTUM (0.53) HDAC1HDAC8HDAC6KDM1AP2RY1
SCHEMBL1222469 0.82 NOTUM (0.53) HDAC1HDAC8HDAC6KDM1AP2RY1
Hydrochloric Acid SCHEMBL25232027 0.81 NOTUM (0.52) HDAC1HDAC8HDAC6KDM1AP2RY1
SCHEMBL1223344 0.80 NOTUM (0.41) HDAC1HDAC8HDAC6KDM1ACYP3A4
SCHEMBL1195029 0.79 AKT1 (0.41) HDAC1HDAC8HDAC6KDM1ANOTUM
SCHEMBL6002974 0.79 CYP11B2 (0.38) HDAC1HDAC8HDAC6KDM1AP2RY1
SCHEMBL20955744 0.79 NOTUM (0.57) HDAC1HDAC8HDAC6KDM1AMEN1
SCHEMBL20955027 0.79 KDM4E (0.43) HDAC1HDAC8HDAC6PDE4BHTT
Hydrochloric Acid SCHEMBL17008459 0.78 AKT1 (0.41) HDAC1HDAC8HDAC6KDM1ANOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005063745-A9 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARM INC (US) 2007-02-01 WO disclosed
EP-1716148-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF Arena Pharmaceuticals, Inc. (US) 2006-11-02 EP disclosed
WO-2005063745-A2 NOVEL SPIROINDOLINE OR SPIROISOQUINOLINE COMPOUNDS, METHODS OF USE AND COMPOSITIONS THEREOF ARENA PHARMACEUTICALS, INC. (US) 2005-07-14 WO disclosed